UTI CEO Grant Jerome Alan sold 94,500 shares at $41.40, reducing directly held shares by 22.0% to 335,715, with the stock trading 31.8% above its 90-day low and 9.5% below its 90-day high. This $3.9M sale is his largest on record — topping the $2.1M sold in February 2026 — and arrives as the fifth consecutive sell event with zero buys across 29 Form 4 filings since 2017, forming a consistent distribution pattern that now clusters with a Division President sale ($182K, June 25) and a Coliseum Capital block exit ($124M, June 10). Bull case: STRONG BUY consensus holds and the stock reclaims $45.74; bear case: accelerating insider supply combined with a thin $0.05 EPS consensus for August 4 earnings breaks the $36.12 30-day low.

Where it could go — Broad base rate 41.7% positive at 90d for similar sells; bull holds $41.40 support, bear breaks $36.12.

Concorde Division President Kevin Prehn sold $182K worth of UTI shares, reducing his direct holdings by 14.4% at $40.00 per share. This first-ever sale comes amid a STRONG BUY analyst consensus but follows recent bearish insider activity at the company.

Where it could go — 41.7% of similar setups result in positive 90d returns; watch $36.12 as bear break level.

Director Coliseum Capital Management sold $124.2M in UTI shares at $41.40, reducing its stake by 75.5% from a position near the 90-day high. This large-scale exit by a frequent seller, with no other insider buyers in the last 60 days, suggests a significant reduction in conviction despite a STRONG BUY analyst consensus.

Where it could go — Analyst mean target not provided; bear case if stock breaks the recent low of $31.42.

SVP & CAO Christine Kline sold $155K worth of shares, reducing her stake by 7.5% at a price 41.4% above the 90-day low. This first-ever sale is a routine diversification event, lacking the corroboration of other insider buying to signal deeper concern.

Where it could go — Analyst mean target not provided; bear case if stock breaks below the recent low of $31.42.

Director Linda J. Sreere filed a Form 4 Code-S (open-market sale) for $549K, reducing her stake by 10.5%. This is her first recorded transaction, with no prior Code-P buys or Code-S sells on file. The sale at $36.59 is 40.0% above the 90-day low, and analyst consensus remains a Strong Buy with 10 buy ratings.

Where it could go — If the bear case plays out, the stock may test the 90-day low of $26.13; the bull case requires the stock to hold above the $31.42 30-day low and align with the analyst consensus.